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Background: Knowledge about time trends of disease patterns in society is essential for plan-
ning and prioritizing health care resources. Longitudinal population-based studies on asthma
are scarce but provide an opportunity to assess incidence, remission and relapse of asthma,
and their determinants, which were the objectives of the present study.
Methods: A postal questionnaire was sent on two occasions, 1996 and 2006, to a randomly
selected sample of subjects aged 20e69 years in 1996. The response rates were 72% and
83%, respectively, and in total 4479 subjects participated in both surveys. The questionnaire
included questions on asthma, respiratory symptoms and possible determinants. Logistic
regression was used to assess determinants.
Results: Cumulative incidence of asthma was 2.4% (men 1.9%; women 2.8%, pZ 0.06). Family
histories of asthma (OR 2.31, CI 95% 1.42e3.76), rhinitis (OR 2.25, CI 95% 1.43e3.53) and being
an ex-smoker (OR 2.17, CI 95% 1.27e3.71) were determinants for incident asthma. The 10-year
remission of asthma was 14.6% and inversely associated with rhinitis. Relapse was found in 38%
of eligible subjects.1 342 4144; fax: þ46 31 413 290.
u.se (L. Ekerljung).
8 Elsevier Ltd. All rights reserved.
Asthma incidence, remission and relapse 1731Conclusions: The current study with high participation rates concludes that the incidence of
asthma among adults has been stable in Sweden for the past two decades. Remission was asso-
ciated with mild disease at study start. Relapse in adults has rarely been reported previously
and provide new insight in the course of asthma. Low remission and high relapse further
support the view of asthma as a chronic disease; possibly representing fluctuations of the
disease over time.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
The prevalence of asthma has increased in most parts over
the world during the second half of the 20th century. While
the prevalence of asthma has been frequently studied
studies of the incidence of asthma are still scarce.1e7 There
is a tendency towards higher incidence rates in more recent
studies compared to older studies,8 likely indicating an
increase in asthma incidence during the last 30e40 years,
a result also found in Sweden.9 It is, however, not clear
whether the increase is still continuing.
The incidence rate varies extensively between different
studies, ranging from 0.4 to 11/1000/year.5 This discrep-
ancy has several reasons and consideration of the used
methods and definitions are of great importance when
comparing studies of incidence of asthma. The definition of
population at risk is critical for the outcome,5,10 and
subjects with symptoms common in asthma at the start of
the study can be excluded from the population at risk to
compensate for changes in diagnostic criteria.5,7 When
individuals with symptoms at study start have been
excluded, similar incidence rates of physician-diagnosed
asthma of w2/1000/year has been reported from the
Obstructive Lung Disease in Northern Sweden (OLIN) studies
1986e19965 and the Respiratory Health in Northern Europe
study (RHINE) 1990e2000/2002.7 Studies without correction
for common asthma symptoms at entry report higher inci-
dence rates.4,6
Until recently only a few studies focused on remission of
adult asthma based on the general population have been
published.11e13 As different definitions of remission have
been used, the reported remission rates vary, ranging from
0.4 to 2/100 asthmatics/year including results from two
recent studies using similar definitions of remission.14,15
Only one study has specifically examined remission of
respiratory symptoms.16 To the authors’ knowledge only one
study of relapse in adult age has been published to date.11
The present study is a 10-year follow-up of a survey per-
formed in the city of Stockholm in 1996 and examined inci-
dence, remission and relapse of adult asthma and their
covariates.
Material and methods
Study population
The study started in 1996 when 8000 randomly selected
subjects in the city of Stockholm, aged 20e69 years,17,18
were identified using the Swedish Population Register which
also provided the addresses. Completed answers were
received from 5754 subjects (71.9%). A 10-year follow-up
was performed among the 5372 (93.4%) subjects who couldbe traced in the winter of 2006, using the same method and
questions.18
Methods
The study consisted of a postal self-administered ques-
tionnaire. Non-responders received two reminders. The
questionnaire was developed from a Swedish question-
naire19 based mainly on the British MRC questionnaire20 and
contained questions on asthma, rhinitis, respiratory symp-
toms and use of asthma medication. Included symptoms
were, among others, recurrent wheeze and attacks of
shortness of breath (SOB). Smoking habits, occupation and
family history of diseases were also investigated.
Definitions
Ever asthma: ‘‘Have you ever had asthma’’; Physician-
diagnosed asthma: ‘‘Have you been diagnosed as having
asthma by a doctor’’; Asthma medicine: ‘‘Do you currently
use asthma medicine (permanently or as needed)’’; Attacks
of shortness of breath: ‘‘Do you presently have, or have
had in the last 10 years, asthma symptoms (intermittent
breathlessness or attacks of shortness of breath; the
symptoms may exist simultaneously with or without cough
or wheezing)’’ and ‘‘Have you had these problems within
the last year’’; Recurrent wheeze: ‘‘Do you usually have
wheezing or whistling in your chest when breathing’’; Any
wheeze: ‘‘Have you had whistling or wheezing in the chest
at any occasion during the last 12 months’’.
Five smoking categories were defined. Smokers reported
smoking at both occasions. Ex-smokers reported ex-smoking
at both occasions. Starters and restarters did not smoke or
were ex-smokers in 1996 but smokers in 2006. Quitters
smoked in 1996 but reported ex- or non-smoking in 2006.
Never-smokers were non-smokers both 1996 and 2006. To
be considered as a quitter or an ex-smoker no smoking
during the last 12 months was allowed.
Cumulative incidence is the proportion of subjects with
no physician-diagnosed asthma at the beginning of the
study period which has received an asthma diagnosis at the
end of the study. The cumulative incidence of physician-
diagnosed asthma was calculated using two populations at
risk. Crude cumulative incidence was calculated by
excluding only subjects reporting physician-diagnosed
asthma in 1996 from the population at risk. The population
at risk for adjusted cumulative incidence excluded also
subjects reporting ever asthma, use of asthma medication,
attacks of SOB or recurrent wheeze in 1996. The incidence
rate (ir) was assumed to be linear and was estimated using
the formula irZa=ð10 ðb ða=2ÞÞÞ where a is the incident
cases and b the subjects at risk at the start of the study.
Table 2 Smoking categories including changes in smoking
habits 1996e2006
Smoking group Smoking categories 1996e2006
Men Women Total
n % n % n %
Never-smokers 891 44.5 1102 44.7 1993 44.6
Quitters after 1996 324 16.2 404 16.4 728 16.3
Starters and
restartersa
53 2.6 59 2.4 112 2.5
Ex-smokers already
in 1996
410 20.5 481 19.5 891 19.9
Smokers both in 1996
and 2006
324 16.2 422 17.1 746 16.7
Missing data 2 0.1 4 0.2 6 0.1
a In the analyses starters and restarters have been considered
as smokers.
1732 L. Ekerljung et al.The remission of asthma was defined as having physi-
cian-diagnosed asthma and at least one of recurrent
wheeze, attacks of SOB or use of asthma medication in 1996
but no symptoms or use of asthma medicine during the year
preceding the survey in 2006. Relapse was defined as
physician-diagnosed asthma in 1996 but no wheeze, attacks
of SOB or use of asthma medication in the year preceding
1996 and reporting at least one symptom or use of asthma
medicine in 2006.
Statistical analyses were performed using the Statistical
Package for the Social Sciences (SPSS). The chi-square test
was used for bivariate comparisons. Multiple logistic
regression analysis was performed for assessment of
simultaneous influences of risk factors. Age group, gender,
family history of asthma, rhinitis and smoking categories
were used as covariates. A p-value <0.05 and a 95% confi-
dence interval were considered significant.
Results
Demographics
Of the 5372 invited subjects, 4479 (83.4%) participated. A
majority was still living in the city of Stockholm, while 8.5%
had moved but were retained in the study. The response
rate was significantly higher among women than men,
p< 0.01 and among non-smokers compared to smokers, 79%
vs. 74%, p< 0.01. The highest response rates were observed
in the age group of 61e80 years of age. Of the sample,
16.3% stopped smoking during the 10-year study period
(Table 2) which comprised 49.4% of the smokers in 1996
(Table 1).
Cumulative incidence and estimated incidence rate
The crude cumulative incidence was calculated by
removing the subjects reporting physician-diagnosed
asthma in 1996 from the population at risk, the remaining
54 men (2.9%) and 105 women (4.6%) reporting physician-
diagnosed asthma in 2006 represent the crude cumulative
incidence of 3.8% (Fig. 1). By also removing the subjects
reporting ever asthma, use of asthma medication, recur-
rent wheeze or attacks of SOB in 1996 from the risk pop-
ulation, the adjusted cumulative incidence was calculated
at 2.4% (men 1.9%; women 2.8%). A higher crudeTable 1 Demographics in 1996 for responders and non-
responders in 2006
Study population Responders Non-responders
Mean Std Mean Std
Age 52 13 50 14
n % n %
Women 2474 55 625 49
Smokers 1342 30 464 37
Ex-smokers 900 20 237 19
Non-smokers 2169 49 551 44
Physician-diagnosed asthma 342 8 98 8
Longstanding cough 608 14 201 16(pZ 0.004) and adjusted (pZ 0.06) cumulative incidence
was found among women than in men (Fig. 1). The adjusted
cumulative incidence was highest in ages 30e50 and 70e80
years and lowest in ages 50e70 years (Fig. 2).
The annual incidence rate was estimated assuming the
number of incident asthma cases to be constant. Thus the
estimated crude incidence rate was 3.9 cases/1000/year
and the adjusted incidence rate was 2.4 cases/1000/year.
Characteristics and risk factors of incident asthma
Of the 87 subjects with adjusted cumulative incident
asthma, 68% reported attacks of SOB, 61% any wheeze, 32%
recurrent wheeze, 72% use of asthma medication and 55%
rhinitis. Non-smokers constituted 38% of the cases, 10%
were smokers and 31% were ex-smokers. The majority were
women (64%) and 56% were young adults aged 20e40 years
in 1996. In a multivariate logistic regression analysis family
history of asthma (OR 2.31, CI 95% 1.42e3.76), rhinitis (OR
2.25, CI 95% 1.43e3.53) and being an ex-smoker (OR 2.17,
CI 95% 1.27e3.71) were all significant risk factors for
adjusted incident asthma, while female sex did not reach
statistical significance (Table 3).
Remission
In 1996, 295 subjects reported current asthma, i.e. physi-
cian-diagnosed asthma with symptoms or use of asthmap
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Asthma incidence, remission and relapse 1733medication during the year preceding the survey in 1996.
Using the above-mentioned definition, remission was found
in 43 subjects. Hence, the 10-year remission was 14.6%.
Remission was found in 12 men (11%) and 31 women (17%),
pZ 0.16. Subjects with remission had significantly less
symptoms in 1996 and used asthma medication to a lesser
degree (Fig. 3). Neither gender, age, a family history of
asthma nor smoking habits had a significant effect on the
probability of remission. Having rhinitis was inversely
associated with remission (Table 3).
Relapse
In 1996, 47 subjects reported physician-diagnosed asthma
but had not experienced asthma symptoms or use of asthma
medication during the year prior to study entry. In 2006, 18
(38%) of these had relapse reporting at least one symptom,
i.e. any wheeze (67%), recurrent wheeze (22%), attacks ofTable 3 Risk factors for crude incidence, adjusted incidence a
Independent variables Dependent variables
Incidence of crude asthma
Variables Categories OR 95% CI
Age 30e40 1.00
41e50 1.04 0.67e1.63
51e60 0.77 0.47e1.26
61e70 0.8 0.46e1.38
71e80 1.27 0.72e2.23
Gender Men 1.00
Women 1.49 1.06e2.09
Family history No 1.00
Yes 4.15 2.97e5.79
Rhinitis No 1.00
Yes 2.74 1.97e3.81
Smoking Non-smokers 1.00
Quitters 1.49 0.95e2.33
Ex-smokers 1.58 1.03e2.42
Smokers 1.02 0.63e1.66SOB (83%) or use of asthma medication (50%). Relapse was
found in 7 men (29%) and 11 women (48%). None of the
variables gender, age or smoking habits was associated with
relapse assessed by a risk factor analysis. Subjects with
a family history of asthma experienced relapse to a higher
degree than subjects with no family history of asthma (OR
5.31, CI 95% 1.02e27.65).
Discussion
We report data on incidence, remission and relapse of adult
asthma from a large population-based cohort with a high
response rate. There is no evidence of a further increase in
asthma incidence in Sweden when the present study, per-
formed 1996e2006, and previous studies, performed 1986e
1996 and 1990e2000, are viewed concurrently.5,7 The
concept of asthma as a chronic disease was further verified
with the findings of a low remission rate and a high relapse
of physician-diagnosed asthma. A family history of asthma,
rhinitis, being an ex-smoker and female sex was determi-
nant of incident asthma.
Longitudinal studies of asthma are still sparse and have
been focused on the incidence of asthma1e10 and only rarely
on remission.11e15 Studies of relapse of asthma have been
based on cohorts of children. The British 1958 birth cohort
study21,22 and the Dunedin Multidisciplinary Health and
Development study23,24 have followed cohorts of children to
adult age. Studies of relapse in adult age are very scarce.11
Studies of the incidence of asthma have been both
retrospective9 and prospective1e7,10 and the reported
incidence varies extensively. This variation is greatly
influenced by several factors including the method used,
the cohort’s age composition, the definition of population
at risk and the criteria of disease, which all vary across
previous studies.5,25,26 Retrospective studies generally
report lower incidence rates,9,25 and prospective studiesnd remission of asthma
Incidence of adjusted asthma Remission of asthma
OR 95% CI OR 95% CI
1.00 1.00
0.98 0.55e1.76 0.62 0.24e1.61
0.54 0.27e1.09 0.56 0.20e1.56
0.67 0.33e1.39 0.82 0.30e2.26
1.18 0.58e2.40 0.43 0.12e1.47
1.00 1.00
1.39 0.89e2.18 1.63 0.78e3.37
1.00 1.00
4.33 2.78e6.76 0.91 0.45e1.85
1.00 1.00
2.21 1.41e3.48 0.33 0.16e0.67
1.00 1.00
1.56 0.85e2.84 0.97 0.39e2.42
2.05 1.20e3.52 1.51 0.63e3.65
0.84 0.40e1.73 0.53 0.16e1.69
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Figure 3 Symptoms in 1996 for subjects with and without
remission in 2006.
1734 L. Ekerljung et al.with other definitions of population at risk report higher
incidence rates since also non-diagnosed asthmatics at
study start will be considered incident cases.
When comparing asthma incidence over time, or
between geographical regions, using the same method is
paramount for the results to be meaningful. Interestingly,
the adjusted incidence rate of 2.4 cases/1000/year
reported in this study running from 1996 to 2006 is similar
to the incidence rate of 2.3/1000/year found in the OLIN
studies from 1986 to 19965 and RHINE studies from 1990 to
2000 that reported 2.1/1000/year7 (Fig. 4). These longi-
tudinal studies over 10 years used the same method and
similar definitions of population at risk, and we therefore
conclude that the incidence of asthma among adults in
Sweden has stabilized. Some other studies have shown
that the prevalence of asthma is still increasing.6,17,27 The
prevalence increase in respiratory symptoms and asthma in
our cohort can be explained as an age-effect, as most
symptoms increase by age. Whether or not asthma and
symptoms are increasing in the society cannot be discussed
based on our data. Our study was not a cross-sectional
study, and thus it is not advisable to view the data as an
actual increase in prevalence in the society, and hence
these data are not shown. The increase in prevalence
without increase in incidence has two main explanations.
First, the incidence of asthma has increased in children
and adolescents,28,29 and these subjects carry their0
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Figure 4 Adjusted incidence rates in recent Swedish longi-
tudinal studies.disease into adult age.23,30 Secondly, today, more patients
with a milder disease are diagnosed with asthma than
previously.5
A longitudinal study set-up is the only way to correctly
calculate incidence and remission of asthma and it provides
great advantages over cross-sectional studies when non-
constant risk factors are assessed.4 If the studied disease
has a low incidence, as asthma, large populations and/or
long observation periods are necessary to identify deter-
minants of disease.
Our finding that a family history of asthma was
strongly associated with incident adult asthma is consis-
tent with previous studies.4,9,31 Rhinitis was the second
strongest risk factor for incident asthma. We believe
rhinitis is a reasonable surrogate marker of allergic
sensitization, which differentiates between allergic and
non-allergic asthma. In analogy to children,32 different
patterns of risk factors could be expected for allergic
and non-allergic asthma. However, larger studies are
needed to study this in population-based samples of
adults. The incidence of physician-diagnosed asthma was
higher among women compared to men as found in other
studies.5,7,9,26
The impact of smoking on asthma onset is controversial,
as several studies report an increased risk5,9 which other
prospective studies have failed to confirm.10,33,34 We found
a significant association between ex-smoking and incident
asthma, and a positive trend among those who quit
smoking. This was not observed in smokers. One explana-
tion may be that those who experience respiratory symp-
toms tend to stop smoking, while smokers with no
respiratory symptoms continue smoking, the ‘‘healthy
smoker effect’’.35 These associations underline the impor-
tance of prospective population-based studies.
We found the remission over 10 years to be 14.6% and
together with previous reports a homogenous picture with
remission rates of about 1e2/100 asthmatics/year12e15
emerges. Studies of remission of asthma in children and
adolescents report higher remission rates.11,24 Additional
studies using the same definitions are essential to confirm
the results. Remission of asthma was associated with mild
disease prior to the first survey. The negative association
between rhinitis and remission from asthma has been
described previously.11e15
The single available study of relapse among adult
asthmatics with no symptoms or medications was con-
ducted in 1972e198111 and reported a relapse rate of 38%
over 9 years, similar to our study. Information on relapse
has been investigated in child cohorts21e24 of which one
has been followed-up at 42 years of age and relapse was
rarer among adults than among children. In our 10-year
study of an adult population, we have no information on
childhood symptoms. This might underestimate the relapse
rate since childhood symptoms are not remembered in up
to 1/3 of adult subjects,21 and as a consequence also the
true incidence rate could be somewhat lower than the
found. Risk factor analysis was performed for relapse, but
the subjects were too few to draw conclusions.
The validity of the current study must be considered
high as it is a large longitudinal study with an excellent
response rate. The responders at both surveys were highly
representative of the original study population, supporting
Asthma incidence, remission and relapse 1735a high internal validity. Moreover, the external validity
must also be considered high with results comparable to
several well-performed longitudinal studies.
In conclusion, this up-to-date longitudinal study with
validated methods and a high participation rate vouch for
solid and reliable results on the incidence, remission and
relapse of adult asthma. In conjunction with previous
studies no indication of an increased incidence of adult
asthma could be seen. A low remission rate in combination
with a high relapse rate strengthens the view of asthma as
a chronic disease. The high relapse rate among subjects in
remission might indicate that remission and relapse only
are transitory variations in the clinical expression of
asthma and further studies with a longer study period are
needed to investigate the dynamics of this flux.Acknowledgements
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